Notably, the presence of a CREB-binding site in the IL-6 promotor region together with the high expression of CREB triggered by the EWSR1::CREB1 fusion has been proposed to explain the IL-6 overexpression observed in this rare tumor type [30–32]. The gene discussed is CREB1; the disease is neoplasm.